DLX6 and prostate cancer: These data suggested that DLX6-AS1 was highly expressed in prostate cancer tissues and cells, and mainly expressed in the nucleus, and DLX6-AS1 depletion could reduce the proliferation, migration, and invasion of prostate cancer cells.